2017
DOI: 10.1111/ped.13269
|View full text |Cite
|
Sign up to set email alerts
|

Clonidine may have a beneficial effect on refractory nocturnal enuresis

Abstract: Clonidine could be an aid for refractory enuresis, although further randomized controlled trials are needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 21 publications
0
9
0
Order By: Relevance
“…Treatment of MPH or AMPH will increase compliance and motivation with better outcomes of incontinence therapy 4,20 . There is also evidence of an antienuretic effect of ADHD medication, especially atomoxetine and clonidine/guanfacine which could lead to synergic effects in the treatment of NE in children with ADHD 55–57 …”
Section: Resultsmentioning
confidence: 99%
“…Treatment of MPH or AMPH will increase compliance and motivation with better outcomes of incontinence therapy 4,20 . There is also evidence of an antienuretic effect of ADHD medication, especially atomoxetine and clonidine/guanfacine which could lead to synergic effects in the treatment of NE in children with ADHD 55–57 …”
Section: Resultsmentioning
confidence: 99%
“…In 30–50% of children with sleep apnoea and enuresis, treatment for the sleep apnoea alone results in a resolution of their enuresis . In children who have sleep problems, the addition of melatonin or clonidine to standard treatment for enuresis resulted in improved treatment outcomes but not if melatonin was used alone (without the addition of other enuresis treatments), suggesting that improving the sleep in these children may result in better treatment response to standard enuresis therapy.…”
Section: Why Standard Treatments For Enuresis Failsmentioning
confidence: 99%
“…4) Tonsillectomy is also a treatment option (23,24). In addition, many researchers have investigated the use of combination therapies (25-28), the underlying mechanisms of the disease (29)(30)(31), and the prognosis and adverse reactions associated with these therapies to improve their efficacy and safety (30,32,33). However, although there has been some theoretical basis in the pathogenesis, there is no consensus.…”
Section: Introductionmentioning
confidence: 99%